We are thrilled to be welcoming four new directors, each of whom has a distinguished professional background and a wealth of expertise to bring to our Board of Directors, partnered with an enthusiasm for our artistic work
Philadelphia, PA (Vocus) September 20, 2010
As the Opera Company of Philadelphia approaches its 35th Anniversary Season, opening on October 1st with Verdi’s Otello, Opera Company Board Chairman Stephen A. Madva is pleased to announce the appointment of four new directors: Willo Carey, Joel Koppelman, Daniel K. Meyer and Scott F. Richard. “We are thrilled to be welcoming four new directors, each of whom has a distinguished professional background and a wealth of expertise to bring to our Board of Directors, partnered with an enthusiasm for our artistic work,” shared Chairman Madva. “We are fortunate to have a Board that is extraordinarily committed to the health and stewardship of opera in Philadelphia, and we are stronger yet with the addition of these four talented individuals.”
Additionally, Opera Company of Philadelphia announces the appointment of Executive Director David B. Devan to the national OPERA America Board of Directors, which governs the national service organization that binds all opera companies in the United States.
New Board Members
Willo Carey is the Executive Director of Wider Horizons, a multimedia service for its 50+ audience developed by WHYY public media in Greater Philadelphia. A member of the WHYY team since 1981, Ms. Carey serves on the External Advisory Board of the University of Pennsylvania’s Institute on Aging and the Advisory Board of the Delaware Valley Schweitzer Fellows Program, and is past Vice Chair of the Philadelphia Corporation for Aging. She is the host of the Philadelphia Orchestra Concert Series produced and broadcast by SpectiCast. A graduate of Mount Holyoke College, Ms. Carey did graduate work in sculpture at Tyler School of Art in Rome.
Joel Koppelman is the Senior Vice President and General Manager of Oracle Primavera Global Business Unit. Mr. Koppelman co-founded Primavera Systems in 1983, and was its CEO until its acquisition by Oracle in 2008. A graduate of Drexel University’s engineering program who received his M.B.A. at the Wharton School of University of Pennsylvania, Mr. Koppelman is a member of the Drexel University Board of Trustees, and he co-authored “Earned Value Project Management,” now in its third edition, and has been published in the Harvard Business Review among other professional journals.
Daniel K. Meyer, MD is the Program Director for the Division of Infectious Diseases at Cooper University Hospital in Camden, New Jersey, where has also served as an Assistant Professor of Medicine since 2000. Dr. Meyer graduated from Jefferson Medical College of Thomas Jefferson University and did much of his postgraduate training and fellowship work at the Hospital of the University of Pennsylvania. His research has been published in a number of journals and books on the topic of infectious disease. Dr. Meyer is a trustee of Lebanon Valley College, where he received his undergraduate degree in piano performance, and is a member of the Board of Directors for the William Penn Foundation in Philadelphia.
Scott F. Richard, D.B.A. is on faculty at Wharton School of Business at the University of Pennsylvania as Practice Professor of Finance. Prior to Wharton, Dr. Richard was Managing Director at Morgan Stanley Investment Management for over a decade, and before MSIM he was a partner at Miller, Anderson, Sherrerd. His previous academic experience was at Carnegie-Mellon University’s Tepper School of Business and MIT’s Sloan School of Management. His research and writing has been published in several prominent business journals, and he holds positions on the Board of Directors for Buck and Doe Trust (PA) and the Board of Advisors of Kepos Capital (NY).
In addition to these Opera Company of Philadelphia Board of Director appointments, Opera Company of Philadelphia Executive Director David B. Devan has been named as a new member of the national Board of Directors for OPERA America, the nationwide service organization for opera companies. Mr. Devan previously served on the Board of Directors for Opera CA (Canada) during his time as Executive Director of Pacific Opera Victoria. The OPERA America Board of Directors meets three times per year and oversees the organization’s portfolio of programs, including professional development activities, educational offerings and grant opportunities such as The Opera Fund, which supports the development of new operatic work.
The Opera Company of Philadelphia opens its 35th Anniversary Season with the Company Premiere of Verdi’s grandscale Otello, featuring a powerhouse cast of international stars from October 1 – 15 at the Academy of Music. Opera at the Academy also features Gounod’s Romeo & Juliet from February 11-20, 2011 and Puccini’s Tosca from April 29 – May 8, 2011. The intimate Opera at the Perelman Series features the Curtis Opera Theatre production of Janáek’s The Cunning Little Vixen in association with the Opera Company and Kimmel Presents from March 16-20, 2011, and the American Premiere of Hans Werner Henze’s Phaedra from June 3 – 12, 2011. For information, visit operaphila.org. Subscriptions are available through October at 215-732-8400. Tickets to individual performances are sold through Ticket Philadelphia at 215-893-1018.
Tracy C. Galligher